Overview
Sean Yi is a litigation associate in Glaser Weil’s San Diego office, where he focuses on complex commercial litigation. Sean has extensive experience representing clients in civil matters in state and federal courts in diverse industries, including pharmaceuticals, biotechnology, consumer credit reporting, banking, airlines and telecommunications. Sean’s litigation experience involves a wide breadth of commercial claims, including securities fraud actions, contract disputes, class actions, False Claims Act matters, antitrust suits, consumer credit reporting cases and insurance recovery matters for policyholders, among other matters.
Sean also has significant experience advising clients in connection with internal corporate investigations and government investigations, including requests by the U.S. Department of Justice and U.S. Securities and Exchange Commission.
Sean has significant experience in:
- Financial services litigation
- Internal investigations
- Government investigations
Before joining Glaser Weil, Sean was an associate at an Am Law 20 firm. Previously, he clerked for the Honorable Robert S. Huie of the U.S. District Court for the Southern District of California.
Sean earned his J.D. from Cornell University in 2017, where he was an associate and blog editor for the Cornell Journal of Law and Public Policy and a participant in the Langfan Moot Court Competition. He received his B.A. in Classics, magna cum laude, from Princeton University in 2012.
In addition to his commercial practice, Sean is dedicated to pro bono work. He has successfully represented clients in immigration cases, including petitions for Special Immigrant Juvenile Status, asylum and Family Unity Benefits.
Results
Sean’s notable experience includes his representation of:
- A pharmaceutical corporation in a class action lawsuit filed in federal court alleging violations of the False Claims Act.*
- A credit reporting agency in federal lawsuits brought by plaintiffs bringing claims under the Federal Credit Reporting Act*
- The special committee of a U.S. public company in its internal investigation of related-party transactions in the U.S. and China involving company founders and senior executives.*
- A major Indian pharmaceutical company in a class action lawsuit filed in federal court alleging violations of the federal securities laws in connection with a warning letter issued by the U.S. Food and Drug Administration (FDA) to the company.*
* Denotes prior firm experience
Leadership and Community
Member, Federal Bar Association
Committee Member, Twentieth Anniversary of Judith N. Keep Federal Civil Practice Seminar
Clerkships
Law Clerk to the Honorable Robert S. Huie, U.S. District Court for the Southern District of California, 2022-2023
Services
Industries
Education
Cornell Law School, J.D., 2017
Princeton University, B.A., magna cum laude, 2012
Admissions
- California
- New York
Languages
- Ancient Greek
- Latin
Insights This just in.
- Award |Leventhal and Petrossian Recognized Among San Diego Business Journal’s 2024 “Leaders of Influence in Law”
- Award |
- Client News |
- Firm News |